New discovery could predict medical cannabis impairment
The method could be used to help develop better tests and ways of reducing unwanted cognitive effects.
24 results for “impairment”
The method could be used to help develop better tests and ways of reducing unwanted cognitive effects.
The findings could have significant implications for road and workplace testing.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use and will improvise…’
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
People who consumed THC were more likely to recall words that were never shown to them.
The case highlights the need for clear and consistent guidance on driving when prescribed medical cannabis.
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing.
Cannabis had a statistically significant effect on brain function during working memory tasks.
Releaf examines what to consider when exploring this treatment option for yourself or a loved one.
Researchers have published findings from one of the first clinical trials on CBG in humans.
Malta is looked on as a frontrunner of European reform, but consumers are still being prosecuted for importing CBD flower.
Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
The semi-naturalistic study found ‘no notable evidence of driving impairment’ after dosing prescribed cannabis products.
Catch up on the latest cannabis science.
8 in 10 consumers report combining cannabis with exercise, saying it boosts motivation and eases pain.
The Australian state of Victoria has introduced new legislation to support the world-leading trial.